Literature DB >> 3419468

Neurologic sequelae of meningitis.

A L Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3419468     DOI: 10.1056/NEJM198810133191510

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Different seroprevalences of antibodies against Neisseria meningitidis serogroup A and Haemophilus influenzae type b in Sudanese and Swedish children.

Authors:  M A Salih; H Fredlund; S Hugosson; L Bodin; P Olcén
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

2.  Bacterial meningitis in Swaziland: an 18 month prospective study of its impact.

Authors:  H Ford; J Wright
Journal:  J Epidemiol Community Health       Date:  1994-06       Impact factor: 3.710

3.  Clinical evaluation of pneumococcal meningitis in adults over a twelve-year period.

Authors:  G A Bruyn; H P Kremer; S de Marie; G W Padberg; J Hermans; R van Furth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-08       Impact factor: 3.267

4.  Differential effect of p47phox and gp91phox deficiency on the course of Pneumococcal Meningitis.

Authors:  Manuela Schaper; Stephen L Leib; Damian N Meli; Ralf P Brandes; Martin G Täuber; Stephan Christen
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

5.  Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes.

Authors:  E I Tuomanen; K Saukkonen; S Sande; C Cioffe; S D Wright
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

6.  Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM).

Authors:  A Del Maschio; A De Luigi; I Martin-Padura; M Brockhaus; T Bartfai; P Fruscella; L Adorini; G Martino; R Furlan; M G De Simoni; E Dejana
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.